BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21762662)

  • 1. Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model.
    Lyoumi S; Abitbol M; Rainteau D; Karim Z; Bernex F; Oustric V; Millot S; Lettéron P; Heming N; Guillmot L; Montagutelli X; Berdeaux G; Gouya L; Poupon R; Deybach JC; Beaumont C; Puy H
    Gastroenterology; 2011 Oct; 141(4):1509-19, 1519.e1-3. PubMed ID: 21762662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria.
    Meerman L; Koopen NR; Bloks V; Van Goor H; Havinga R; Wolthers BG; Kramer W; Stengelin S; Müller M; Kuipers F; Jansen PL
    Gastroenterology; 1999 Sep; 117(3):696-705. PubMed ID: 10464147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
    Duchartre Y; Petit N; Moya C; Lalanne M; Dubus P; Verneuil Hd; Moreau-Gaudry F; Richard E
    J Hepatol; 2011 Jul; 55(1):162-70. PubMed ID: 21145811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietic protoporphyria. An overview with emphasis on the liver.
    Meerman L
    Scand J Gastroenterol Suppl; 2000; (232):79-85. PubMed ID: 11232498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genotype-phenotype correlation between null-allele mutations in the ferrochelatase gene and liver complication in patients with erythropoietic protoporphyria.
    Minder EI; Gouya L; Schneider-Yin X; Deybach JC
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):91-6. PubMed ID: 11929053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion of hepatobiliary alterations By bone marrow transplantation in a murine model of erythropoietic protoporphyria.
    Fontanellas A; Mazurier F; Landry M; Taine L; Morel C; Larou M; Daniel JY; Montagutelli X; de Salamanca RE; de Verneuil H
    Hepatology; 2000 Jul; 32(1):73-81. PubMed ID: 10869291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
    Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
    Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria.
    Wang P; Sachar M; Lu J; Shehu AI; Zhu J; Chen J; Liu K; Anderson KE; Xie W; Gonzalez FJ; Klaassen CD; Ma X
    Sci Adv; 2019 Sep; 5(9):eaaw6127. PubMed ID: 31555729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver metabolomics in a mouse model of erythropoietic protoporphyria.
    Wang P; Sachar M; Guo GL; Shehu AI; Lu J; Zhong XB; Ma X
    Biochem Pharmacol; 2018 Aug; 154():474-481. PubMed ID: 29906468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model provides evidence that genetic background modulates anemia and liver injury in erythropoietic protoporphyria.
    Abitbol M; Bernex F; Puy H; Jouault H; Deybach JC; Guénet JL; Montagutelli X
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1208-16. PubMed ID: 15677551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: potential novel players in the progression of liver injury.
    Berasain C; Sampedro A; Mauleón I; Goñi S; Latasa MU; Matscheko N; García-Bravo M; Unzu C; Corrales FJ; Enríquez de Salamanca R; Prieto J; Avila MA; Fontanellas A
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):29-37. PubMed ID: 19267999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal Phenotyping of Ferrochelatase Mutant Mice Reveals Protoporphyrin Accumulation and Reduced Neovascular Response.
    Sardar Pasha SPB; Shetty T; Lambert-Cheatham NA; Sishtla K; Mathew D; Muniyandi A; Patwari N; Bhatwadekar AD; Corson TW
    Invest Ophthalmol Vis Sci; 2021 Feb; 62(2):36. PubMed ID: 33620374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
    Pawliuk R; Tighe R; Wise RJ; Mathews-Roth MM; Leboulch P
    J Invest Dermatol; 2005 Jan; 124(1):256-62. PubMed ID: 15654982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased mitochondrial respiratory chain enzyme activities correlate with minor extent of liver damage in mice suffering from erythropoietic protoporphyria.
    Navarro S; Del Hoyo P; Campos Y; Abitbol M; Morán-Jiménez MJ; García-Bravo M; Ochoa P; Grau M; Montagutelli X; Frank J; Garesse R; Arenas J; de Salamanca RE; Fontanellas A
    Exp Dermatol; 2005 Jan; 14(1):26-33. PubMed ID: 15660916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver pathology and hepatocarcinogenesis in a long-term mouse model of erythropoietic protoporphyria.
    Libbrecht L; Meerman L; Kuipers F; Roskams T; Desmet V; Jansen P
    J Pathol; 2003 Feb; 199(2):191-200. PubMed ID: 12533832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperlipidemia and atherosclerosis associated with liver disease in ferrochelatase-deficient mice.
    Bloks VW; Plösch T; van Goor H; Roelofsen H; Baller J; Havinga R; Verkade HJ; van Tol A; Jansen PL; Kuipers F
    J Lipid Res; 2001 Jan; 42(1):41-50. PubMed ID: 11160364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockout of the primary sclerosing cholangitis-risk gene Fut2 causes liver disease in mice.
    Maroni L; Hohenester SD; van de Graaf SFJ; Tolenaars D; van Lienden K; Verheij J; Marzioni M; Karlsen TH; Oude Elferink RPJ; Beuers U
    Hepatology; 2017 Aug; 66(2):542-554. PubMed ID: 28056490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
    Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
    Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice.
    Lyoumi S; Abitbol M; Andrieu V; Henin D; Robert E; Schmitt C; Gouya L; de Verneuil H; Deybach JC; Montagutelli X; Beaumont C; Puy H
    Blood; 2007 Jan; 109(2):811-8. PubMed ID: 17003376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of protoporphyrin IX in erythrocytes in a case of acquired erythropoietic protoporphyria.
    Heerfordt IM; Fontenete S; Lerche CM; Wulf HC
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102629. PubMed ID: 34798346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.